Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer Biotech Investing
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary Biotech Investing
C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society Annual Meeting Biotech Investing
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status Biotech Investing
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Biotech Investing
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications Biotech Investing
AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS Biotech Investing
